"Lucence presented promising new data on earlier cancer detection based on AmpliMark, its amplicon-based next generation sequencing technology at the 60th Annual ASCO Meeting in Chicago, May 31 – Jun 4, 2024."
"Lucence will present promising new data on earlier cancer detection based on AmpliMark, its amplicon-based next generation sequencing technology at the 59th Annual ASCO Meeting in Chicago, June 2-6, 2023."